Comparative Effectiveness Research f Children for Child with ith Chronic Ch i Conditions: C diti A Canadian Perspective Astrid Guttmann MDCM, MSc Division of Paediatric Medicine, Hospital for Sick Children Department of Paediatrics Paediatrics, Faculty of Medicine Medicine, University of Toronto Institute for Clinical Evaluative Sciences Department of Health Policy, Management and Evaluation, University of Toronto Enhancing the effectiveness of health care for Ontarians through research Disclosure • Astrid Guttmann has no conflicts of interests to disclose Main Messages • • • • • Nott all N ll important i t t questions ti will ill be b on the th “top “t 20” CER or policymaker list Need to work to get children’s issues on the radar “Complex” Complex interventions may not lend themselves to pragmatic trials but “new” ones are ideal candidates Observational research will have a role but depend p on best practice p existing g need strong methods Admin d data is s a sta starting t g po pointt for o many a y quest questions o s As in US researcher capacity a BIG issue General Landscape of CER* in Canada • Provinces have healthcare jurisdiction • Ontario as an example • Ministry of Health Medical Advisory Secretariat • Inform policy/funding decisions on new interventions or “investments” in disease groups • Systematic reviews and commission field studies Ontario Drug Benefit Plan • Funding decisions on drugs to be covered * We used to call this hsr… Enhancing the effectiveness of health care for Ontarians through research Ontario landscape cont’d • Research institutes – ICES Funded by MOH but independent Most administrative data sets housed and linked – for use for research and informing policy Universal healthcare system – population-based Enhancing the effectiveness of health care for Ontarians through research Examples E l off research/policy h/ li collaborations • • Prospective studies with funding decisions riding on results Implantable cardiac defibrillator Field study, admin data component • Wound Care Trial (home care)*** Stepped pp wedge g design g *** • Ideal CER Randomized design Population Population-based based Knowledge user (policymaker) involved in design integrated knowledge translation Funded F d d by b knowledge k l d user with ith complete researcher independence Oth forms Other f off CER – observational b ti l studies • Evaluations of current policies/interventions Drugs – post marketing surveillance Cardiac stents • Mixed Mi d methods th d Capitalizing on the “natural experiment” of variations in care provision • Order sets in ED asthma care for children Advantages in Canada • Strong relationships between MOH • • and d researchers h –> > evaluation l ti Potential to “control” intervention Administrative data for use within privacy legislation population based relatively complete across sectors Ability to add other data Challenges • R words – randomize, research • If policies “rolled” out rather than • • y hard to scale back “trialed” – very New data collection almost always needed Observational – confounding by indication – need STRONG METHODS (propensity scores, IV) CER A Activities ti iti around d Child Children with ith Chronic Conditions • Focus on validating disease definitions in administrative data Asthma To et al, 2005 Pediatr Allergy Immunol Diabetes Guttmann et al, 2009 Pediatric Diabetes Inflammatory bowel disease Benchimol et al 2009 Gut • Aligning with current governmental priorities Technology dependent Complex Chronic Conditions Top “CER” issues in Ontario • Models of care Care coordination for children with p care needs complex • Medically fragile • Complex p obesity y • Multi-diagnosis mental health Transition care for youth to adult care Mean age at death, 1950-2003 Age ((yrs) 50 45 5 All CA Spina bifida CHD Down's 40 35 30 25 20 15 10 5 0 1950 1960 of health 1970 Enhancing the effectiveness care 1980 1990 2000 for Ontarians through research R.Wilkins Health Canada 2007 Transition T iti to t Adult Ad lt Care C for f Youth Y th with Chronic Conditions • Multi-facetted issue • Care Physician Multi-disciplinary team • Financing Devices, e ces, ot other e se services ces • Timing • Lack of evidence on best practice Freed et al 2006 Main transition program services • Disease-specific model • Subspecialty model • Adolescent health model • Primary Care model Ontario Pediatric Diabetes Network Methods • Survey of modes of transition • Administrative health data for outcomes • • (admissions, eye care) Compared outcomes post- to pretransition Assumed that allocation to diabetes centre based on location and within patient analysis minimized confounding… Youth with DM by mode of transition Method of Transition N % Change of MD and DM team 969 64 Change of MD only 383 25 No change g 29 2 Change of DM Team only 65 4 Change of MD, no DM team follow up 61 4 Relative R l ti risk i k off admissions d i i for f diabetes di b t complications after transition to adult care Method of Transition Relative Risk (95% CI) New MD and team 1.00 New MD only 0.79 (0.52-1.18) No change 0.09 (0.003-0.71) New Team only 0 23 (0 0.23 (0.005-0.79) 005 0 79) Future Directions • Collecting more granular data on • transition programs – add other p provinces Evaluate network itself O l Canadian Only C di province i with ith one • ?improved access to specialized care, b tt outcomes better t Current or Planned Work • Insulin pumps for children and youth with T1DMm • Care coordination for children with complex p conditions • Best practice for improving ED care for children with asthma -- needs a trial • Best care for IBD – including new data on disease severity +/- genotypes • Whatever Wh t is i mostt policy li relevant l t and d where there is researcher interest Main Messages • Not all important questions will be on the “top 20” CER or policymaker list • • “Complex” interventions may not lend themselves to pragmatic trials but “new” ones are ideal candidates Observational research will have a role • • Need to work to get children’s issues on the radar but depend on best practice existing need strong g methods Admin data is a starting point for many questions As in US researcher capacity a BIG issue